Advertisement

Topics

Diplomat accompanies solid Q3 results with another acquisition

15:53 EST 7 Nov 2017 | Drug Store News

Diplomat’s CEO and chairman, Phil Hagerman, said the acquisition of National Pharmaceutical Services is a way of responding to patient and employer demands for flexible methods aimed at improving outcomes and reduced costs.

read more

Original Article: Diplomat accompanies solid Q3 results with another acquisition

NEXT ARTICLE

More From BioPortfolio on "Diplomat accompanies solid Q3 results with another acquisition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...